about
Investigational peptide and peptidomimetic μ and δ opioid receptor agonists in the relief of painOpioid-induced bowel dysfunction: prevalence, pathophysiology and burdenThe effect of naloxone treatment on opioid-induced side effects: A meta-analysis of randomized and controlled trailsOxycodone/Naloxone: role in chronic pain management, opioid-induced constipation, and abuse deterrenceAn oral TRPV1 antagonist attenuates laser radiant-heat-evoked potentials and pain ratings from UV(B)-inflamed and normal skinEffects of chronic fentanyl administration on physical performance of aged ratsAnalgesic properties of a peripherally acting and GalR2 receptor-preferring galanin analog in inflammatory, neuropathic, and acute pain models.Quality of life and healthcare resource in patients receiving opioids for chronic pain: a review of the place of oxycodone/naloxoneMethylnaltrexone in the treatment of opioid-induced constipationPreventive medication use among persons with limited life expectancy.Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipationThe itchy scalp--scratching for an explanation.Pruritus in the elderly: clinical approaches to the improvement of quality of life.A Review of Potential Adverse Effects of Long-Term Opioid Therapy: A Practitioner's GuideThe effect of acupuncture on relieving pain after inguinal surgeriesA primary care-based interdisciplinary team approach to the treatment of chronic pain utilizing a pragmatic clinical trials framework.Pharmacological traits of delta opioid receptors: pitfalls or opportunities?Sigma receptors [σRs]: biology in normal and diseased statesReview of oral oxymorphone in the management of pain.Characterization of methadone as a β-arrestin-biased μ-opioid receptor agonist.Increased Burden of Healthcare Utilization and Cost Associated with Opioid-Related Constipation Among Patients with Noncancer PainEstimating the Effect of Intravenous Acetaminophen for Postoperative Pain Management on Length of Stay and Inpatient Hospital Costs.Health Care Utilization and Costs Associated with Nausea and Vomiting in Patients Receiving Oral Immediate-Release Opioids for Outpatient Acute Pain Management.Postoperative Pain Management in DIEP Flap Breast Reconstruction: Identification of Patients With Poor Pain Control.In vivo antinociception of potent mu opioid agonist tetrapeptide analogues and comparison with a compact opioid agonist-neurokinin 1 receptor antagonist chimeraIntravenous Midazolam as More Effective Than Propofol for Preventing Pruritus After Intrathecal Sufentanil in Surgical Patients: A Randomized Blinded Trial.Interdisciplinary team-based care for patients with chronic pain on long-term opioid treatment in primary care (PPACT) - Protocol for a pragmatic cluster randomized trial.Administration of intravenous morphine for acute pain in the emergency department inflicts an economic burden in Europe.Resource use and costs associated with opioid-induced constipation following total hip or total knee replacement surgery.
P2860
Q26863769-D6F1D5B5-6B81-4E68-AE4D-452C576A20A3Q28209970-04067D7B-F9A3-4FDF-8598-FAB886ABD358Q33595205-21C3CEF8-FBCE-4E54-BD1B-EB3E419D850BQ33938740-05443C67-3F3D-4F91-B009-E26AEE1902D2Q34330887-345705D6-37B0-464D-A919-D85B0D70762EQ34388559-44AB9CF0-18D2-473E-AB7B-FDC0E8986626Q34785603-9132DADB-62E1-4947-958C-8E59B80E349CQ34798408-23216408-FD70-4E30-8632-B6313812F8E3Q35026245-76CE5F91-98A3-43BA-B7F1-903F2F16139EQ35055271-EDE2E2BF-CA50-40E8-99D2-84149548CE7CQ35174654-DE0A737A-70C3-4A9E-89CB-5CE59115FFE5Q35602011-DAC1C356-81FD-4783-B3F8-0FE644449833Q35958649-FC8910E7-BCB9-44C6-8C4D-999A25E25B58Q36302851-BF58C08A-4E43-4BE0-AEA8-4514362860CFQ36536782-61556107-A90A-4C6F-A916-CB7807FD7DAAQ36626553-26C6883B-C80E-46F6-8228-175D03979660Q36920342-FA52C4BB-92E3-4BB1-BB01-A12C52B462A4Q37000551-0769C0E5-08A3-4E7B-88D0-474D6F08A371Q37052760-ECFF0549-977A-4232-9691-3ADFADE4CD93Q37115757-E30640E3-C785-4B2B-AA52-33D18B669193Q37217242-843F4130-FC57-43ED-90A2-156D5768BD8AQ37447614-7744D8A7-7766-4EEE-9022-DEFF78019F7BQ37459026-EC2B9599-4F34-485A-880F-898FD7DFB378Q37791434-A406F57E-281E-4914-8FD1-8B1593E06E2AQ41440337-0C4FFFC5-8A45-433C-A0F4-0CF58C6E83B2Q47093437-7B80DAA2-0BA3-4811-AAC4-71D43E40E0CEQ51742132-4EB91E55-BA39-4056-898B-CB6FF1660DE5Q53822176-A3068E79-3A1D-4DF7-A445-F4855C7854A3Q55054218-DDFDCBAA-7ACA-4860-B183-B8B88927E57E
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Management of common opioid-induced adverse effects.
@ast
Management of common opioid-induced adverse effects.
@en
type
label
Management of common opioid-induced adverse effects.
@ast
Management of common opioid-induced adverse effects.
@en
prefLabel
Management of common opioid-induced adverse effects.
@ast
Management of common opioid-induced adverse effects.
@en
P1476
Management of common opioid-induced adverse effects
@en
P2093
Craig Logemann
John M Swegle
P304
P577
2006-10-01T00:00:00Z